Turnstone Biologics (TSBX) News Today $0.45 -0.01 (-1.91%) (As of 11:15 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BofA downgrades Turnstone to Underperform on unfavorable marketNovember 16, 2024 | markets.businessinsider.comTurnstone Biologics downgraded to Underperform from Neutral at BofANovember 16, 2024 | markets.businessinsider.comLeerink Partners Keeps Their Hold Rating on Turnstone Biologics Corp. (TSBX)November 15, 2024 | markets.businessinsider.comTurnstone Biologics Faces Financial and Operational ChallengesNovember 14, 2024 | markets.businessinsider.comTurnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNovember 12, 2024 | markets.businessinsider.comTurnstone Biologics presents two posters on methods for TIL selection at SITCNovember 6, 2024 | markets.businessinsider.comTurnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 5, 2024 | globenewswire.comB of A Securities Downgrades Turnstone Biologics (TSBX)October 15, 2024 | msn.comTurnstone Biologics Streamlines Operations and LeadershipOctober 12, 2024 | finance.yahoo.comTurnstone Biologics Corp.: Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial RunwayOctober 11, 2024 | finanznachrichten.deTurnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial RunwayOctober 11, 2024 | markets.businessinsider.comTurnstone Biologics To Cut 60% Jobs, Plans Restructuring; CFO Resigns; Stock UpOctober 11, 2024 | markets.businessinsider.comTurnstone Biologics (NASDAQ:TSBX) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comPiper Sandler Remains a Buy on Turnstone Biologics Corp. (TSBX)August 19, 2024 | markets.businessinsider.comTurnstone reports positive early trial results for cancer therapyAugust 16, 2024 | investing.comTurnstone Biologics Corp. (TSBX) Gets a Hold from Leerink PartnersAugust 16, 2024 | markets.businessinsider.comTurnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy StudyAugust 15, 2024 | benzinga.comDow Surges Over 500 Points; US Retail Sales Rise In JulyAugust 15, 2024 | benzinga.comTurnstone Biologics Shares Tumble Following Going Concern WarningAugust 15, 2024 | marketwatch.comTSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024August 14, 2024 | investorplace.comTurnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business HighlightsAugust 14, 2024 | globenewswire.comTurnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal CancerAugust 14, 2024 | globenewswire.comTurnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to AnalystsAugust 13, 2024 | msn.com4 Stocks Under $5 To Buy NowAugust 8, 2024 | 247wallst.comTurnstone Biologics Corp. (NASDAQ:TSBX) Short Interest Down 20.5% in JuneTurnstone Biologics Corp. (NASDAQ:TSBX - Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 519,200 shares, a decline of 20.5% from the June 15th total of 653,400 shares. Approximately 3.8% of the shares of the company are short sold. Based on an average daily trading volume, of 161,100 shares, the short-interest ratio is currently 3.2 days.July 13, 2024 | marketbeat.comPiper Sandler reaffirms Overweight rating on Turnstone Biologics sharesMay 26, 2024 | uk.investing.comLeerink Partners Reaffirms Their Hold Rating on Turnstone Biologics Corp. (TSBX)May 16, 2024 | markets.businessinsider.comTSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024May 13, 2024 | investorplace.comTurnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsMay 13, 2024 | globenewswire.comTurnstone Biologics Corp. (TSBX)May 11, 2024 | finance.yahoo.comTurnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceMay 8, 2024 | globenewswire.comTurnstone Biologics announces board member resignationApril 18, 2024 | uk.investing.comTurnstone Biologics Appoints William Waddill to its Board of DirectorsApril 16, 2024 | globenewswire.comShort Interest in Turnstone Biologics Corp. (NASDAQ:TSBX) Expands By 42.9%Turnstone Biologics Corp. (NASDAQ:TSBX - Get Free Report) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 625,900 shares, a growth of 42.9% from the March 15th total of 438,000 shares. Based on an average daily volume of 181,300 shares, the short-interest ratio is currently 3.5 days. Approximately 4.7% of the company's shares are short sold.April 12, 2024 | marketbeat.comTSBX Turnstone Biologics Corp.April 12, 2024 | seekingalpha.comTSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023March 22, 2024 | investorplace.comTurnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsMarch 21, 2024 | globenewswire.comFmr LLC Buys Shares of 2,830,284 Turnstone Biologics Corp. (NASDAQ:TSBX)Fmr LLC bought a new stake in Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,830,284 shares of the company's stock, valued at approximately $11,1March 7, 2024 | marketbeat.comTurnstone Biologics Corp. (NASDAQ:TSBX) institutional investors have had a good week as stock gains 34%March 2, 2024 | finance.yahoo.comEventide Asset Management LLC Makes New $2.79 Million Investment in Turnstone Biologics Corp. (NASDAQ:TSBX)Eventide Asset Management LLC acquired a new position in shares of Turnstone Biologics Corp. (NASDAQ:TSBX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,317 shares of the company's stock, valued atMarch 1, 2024 | marketbeat.comTurnstone Biologics Stock (NASDAQ:TSBX), Short Interest ReportFebruary 23, 2024 | benzinga.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 21, 2024 | finance.yahoo.comTurnstone Biologics to Participate in Upcoming Investor ConferencesFebruary 21, 2024 | globenewswire.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 20, 2024 | finance.yahoo.comTurnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.February 20, 2024 | globenewswire.comTurnstone Biologics (NASDAQ:TSBX) Stock Price Down 9.6%Turnstone Biologics (NASDAQ:TSBX) Shares Down 9.6%February 1, 2024 | marketbeat.comRUM, ENVB and GAME among mid-day moversJanuary 23, 2024 | msn.comHere's Why Turnstone Biologics (NASDAQ:TSBX) Must Use Its Cash WiselyJanuary 21, 2024 | finance.yahoo.comIPOs In 2023 Disappoint But 2024 Looks BrighterJanuary 3, 2024 | seekingalpha.comTurnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 27, 2023 | finance.yahoo.com Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. TSBX Media Mentions By Week TSBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSBX News Sentiment▼-0.400.47▲Average Medical News Sentiment TSBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSBX Articles This Week▼51▲TSBX Articles Average Week Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Reviva Pharmaceuticals News Today Rallybio News Today CERo Therapeutics News Today CEL-SCI News Today Lumos Pharma News Today OS Therapies News Today NextCure News Today Anebulo Pharmaceuticals News Today Barinthus Biotherapeutics News Today RAPT Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSBX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
